George Roshan P, Mehta Aneesh K, Perez Sebastian D, Winterberg Pamela, Cheeseman Jennifer, Johnson Brandi, Kwun Jean, Monday Stephanie, Stempora Linda, Warshaw Barry, Kirk Allan D
Division of Pediatric Nephrology, Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia;
Division of Pediatric Nephrology, Department of Pediatrics, Emory Transplant Center, Emory University, Atlanta, Georgia; and.
J Am Soc Nephrol. 2017 Jan;28(1):359-367. doi: 10.1681/ASN.2016010053. Epub 2016 Jul 13.
An individual's immune function, susceptibility to infection, and response to immunosuppressive therapy are influenced in part by his/her T cell maturation state. Although childhood is the most dynamic period of immune maturation, scant information regarding the variability of T cell maturation in children with renal disease is available. In this study, we compared the T cell phenotype in children with renal failure (n=80) with that in healthy children (n=20) using multiparameter flow cytometry to detect markers of T cell maturation, exhaustion, and senescence known to influence immune function. We correlated data with the degree of renal failure (dialysis or nondialysis), prior immunosuppression use, and markers of inflammation (C-reactive protein and inflammatory cytokines) to assess the influence of these factors on T cell phenotype. Children with renal disease had highly variable and often markedly skewed maturation phenotypes, including CD4/CD8 ratio reversal, increased terminal effector differentiation in CD8 T cells, reduction in the proportion of naïve T cells, evidence of T cell exhaustion and senescence, and variable loss of T cell CD28 expression. These findings were most significant in patients who had experienced major immune insults, particularly prior immunosuppressive drug exposure. In conclusion, children with renal disease have exceptional heterogeneity in the T cell repertoire. Cognizance of this heterogeneity might inform risk stratification with regard to the balance between infectious risk and response to immunosuppressive therapy, such as that required for autoimmune disease and transplantation.
个体的免疫功能、对感染的易感性以及对免疫抑制治疗的反应部分受其T细胞成熟状态的影响。尽管儿童期是免疫成熟最活跃的时期,但关于肾病患儿T细胞成熟变异性的信息却很少。在本研究中,我们使用多参数流式细胞术检测已知会影响免疫功能的T细胞成熟、耗竭和衰老标志物,比较了肾衰竭患儿(n = 80)和健康儿童(n = 20)的T细胞表型。我们将数据与肾衰竭程度(透析或未透析)、先前免疫抑制治疗的使用情况以及炎症标志物(C反应蛋白和炎性细胞因子)相关联,以评估这些因素对T细胞表型的影响。肾病患儿具有高度可变且常常明显偏态的成熟表型,包括CD4/CD8比值逆转、CD8 T细胞终末效应分化增加、幼稚T细胞比例降低、T细胞耗竭和衰老的证据以及T细胞CD28表达的可变丧失。这些发现在经历过重大免疫损伤的患者中最为显著,尤其是先前接触过免疫抑制药物的患者。总之,肾病患儿的T细胞库具有异常的异质性。认识到这种异质性可能有助于在感染风险与免疫抑制治疗反应之间的平衡方面进行风险分层,例如自身免疫性疾病和移植所需的平衡。